2 hours Travere Therapeutics (NASDAQ:TVTX) Research Coverage Started at ScotiabankMarketBeat
Scotiabank began coverage on Travere Therapeutics in a research report on Wednesday. They set a “sector outperform” rating on the stock.
Nasdaq 100 · Science · Scotiabank
X